Recent developments in vaccination against bovine brucellosis.

Area of Science:

• Veterinary immunology
• Bacteriology
• Epidemiology

Background:

• Bovine brucellosis remains a significant animal health concern.
• Current vaccination strategies aim to minimize serological interference with infection diagnosis.
• Distinguishing vaccinal antibodies from field infection antibodies is crucial for eradication programs.

Purpose of the Study:

• To review advancements in bovine brucellosis vaccine development.
• To highlight strategies for reducing serological responses to vaccination.
• To discuss progress in differentiating vaccinal and infection-induced antibody titers.

Main Methods:

• Review of recent research on Brucella abortus strain 19 and 45/20 vaccines.
• Analysis of methods to reduce vaccine dose and improve serological test specificity.
• Investigation into antibody identification in response to B. abortus 45/20.

Main Results:

• Reduced vaccine doses and improved tests enable adult vaccination alongside test-and-slaughter eradication for strain 19.
• Brucella abortus 45/20 vaccine is increasingly utilized as both a diagnostic aid and protective agent.
• Advancements have been made in identifying specific antibodies generated by the 45/20 vaccine.

Conclusions:

• Vaccine modifications and enhanced diagnostics are improving bovine brucellosis control.
• The 45/20 vaccine shows promise as a dual-purpose tool in managing brucellosis.
• Further research into antibody responses will refine diagnostic capabilities and vaccination strategies.